These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11768034)

  • 1. Palliative chemotherapy in pretreated patients with advanced cancer: oral trofosfamide is effective in ovarian carcinoma.
    Gunsilius E; Gierlich T; Mross K; Gastl G; Unger C
    Cancer Invest; 2001; 19(8):808-11. PubMed ID: 11768034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
    Hartmann JT; Oechsle K; Mayer F; Kanz L; Bokemeyer C
    Anticancer Res; 2003; 23(2C):1899-901. PubMed ID: 12820475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous oral cyclophosphamide as salvage or maintenance therapy in ovarian, primary peritoneal, and fallopian tube cancers: A retrospective, single institute study.
    Wong CN; Wong CN; Liu FS
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):302-305. PubMed ID: 28600037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
    Reichardt P; Pink D; Tilgner J; Kretzschmar A; Thuss-Patience PC; Dörken B
    Onkologie; 2002 Dec; 25(6):541-6. PubMed ID: 12566899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracil.
    Strumberg D; Harstrick A; Klaassen U; Müller C; Eberhardt W; Korn MW; Wilke H; Seeber S
    Anticancer Drugs; 1997 Mar; 8(3):293-5. PubMed ID: 9095336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative chemotherapy with trofosfamide in advanced prostate cancer.
    Salminen EK; Sundström J; Nikkanen V
    Anticancer Res; 2006; 26(1B):539-42. PubMed ID: 16739316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
    Kollmannsberger C; Brugger W; Hartmann JT; Maurer F; Böhm P; Kanz L; Bokemeyer C
    Anticancer Drugs; 1999 Jun; 10(5):453-6. PubMed ID: 10477164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide or trofosfamide in patients with intraocular lymphoma.
    Jahnke K; Thiel E; Bechrakis NE; Willerding G; Kraemer DF; Fischer L; Korfel A
    J Neurooncol; 2009 Jun; 93(2):213-7. PubMed ID: 19099202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy.
    Gebbia V; Martorana F; Scandurra G; Valerio MR; Cufari S; Vigneri P; Sanò MV; Scollo P
    J Oncol Pharm Pract; 2024 Jul; 30(5):853-859. PubMed ID: 37501558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
    Samaritani R; Corrado G; Vizza E; Sbiroli C
    BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative chemotherapy in non-Hodgkin's lymphoma.
    Salminen E; Nikkanen V; Lindholm L
    Oncology; 1997; 54(2):108-11. PubMed ID: 9075780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stabilizing the course of patients with stage IV advanced malignant melanoma by trofosfamide treatment].
    Enk AH; Knop J
    Hautarzt; 2000 Jul; 51(7):486-9. PubMed ID: 10969402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
    Witte HM; Riecke A; Mayer T; Bartscht T; Rades D; Lehnert H; Merz H; Fetscher S; Biersack H; Gebauer N
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):129-136. PubMed ID: 30327940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cyclophosphamide in recurrent ovarian cancer.
    Handolias D; Quinn M; Foo S; Mileshkin L; Grant P; Dutu G; Rischin D
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e154-60. PubMed ID: 23718870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial response of metastatic mucosal melanoma after palliative chemotherapy with trofosfamide: a case report.
    Aigner B; Richtig E; Becker JC; Lingitz H; Marterer R; Niederkorn A; Ugurel S
    J Clin Oncol; 2013 Jan; 31(2):e31-2. PubMed ID: 23213097
    [No Abstract]   [Full Text] [Related]  

  • 16. New insights into the clinical pharmacokinetics of trofosfamide.
    Brinker A; Kisro J; Letsch C; Brüggemann SK; Wagner T
    Int J Clin Pharmacol Ther; 2002 Aug; 40(8):376-81. PubMed ID: 12467306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature.
    Jahnke K; Bechrakis NE; Coupland SE; Schmittel A; Foerster MH; Fischer L; Thiel E; Korfel A
    Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):771-6. PubMed ID: 15349786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer.
    Fleming GF; Waggoner SE; Rotmensch J; Skoog LA; Langhauser C
    Gynecol Oncol; 1997 Apr; 65(1):42-5. PubMed ID: 9103389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide.
    Kopp HG; Kanz L; Hartmann JT
    Anticancer Drugs; 2006 Sep; 17(8):997-8. PubMed ID: 16940811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of advanced ovarian cancer.
    Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
    Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.